RNSystematic ReviewRevista da Escola de Enfermagem da U S P2025

Nursing health technologies in the prevention and control of hepatitis A: a scoping review.

Leonardo Cassimiro Fonseca E Souza, Camila Stela Gomes, Laís Oliveira de Moraes Tavares and 5 others

PMID 40371928

WHAT IT FOUND

Nursing health technologies for hepatitis A prevention and control were mapped in 10 studies as vaccination, testing, education, case management, peer coaching, and electronic reminders.

It maps practices, not proof they work.

Key findings

01The review selected 10 studies.

02The mapped technologies included vaccination, serological testing, health education, reminders in health information systems, peer coaching, case management, consultations, notification, clinical screening, and monitoring/tracking.

03The included studies were reported from the United States and had designs including four experience reports, two cross-sectional studies, one quasi-experimental study, one randomized clinical trial, one qualitative descriptive study, and one retrospective cohort study.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

Only 10 studies were selected, so the map is narrow. The included studies were heterogeneous, and four were experience reports rather than controlled patient studies. The review did not assess risk of bias in the selected studies. The included studies were reported from the United States, so they may not match local systems or nursing scope. It maps technologies used by nursing; it does not show that hepatitis A prevention or control improved.

Declared interests

Financial support was provided in part by CNPq Brasil, process 401923/2024-0; no other conflicts are listed.

The easy way to misread this

Do not read this as proof that nurse-led vaccination, testing, education, or reminders prevent hepatitis A. It maps 10 studies, four were experience reports, and the review did not assess bias.

Read it on PubMed →